Search Results

Qinshan Nuclear Power Membrane Deoxygenation Retrofit Project Put into Operation

Recently, the membrane deoxygenation retrofit project at Qinshan Nuclear Power completed commissioning and was put into operation. The project applies membrane deoxygenation technology to the auxiliary feedwater system (ASG) and reactor boron and water makeup system (REA) of Units 1 and 2 at Qinshan Nuclear Power Plant Phase II, optimizing and upgrading the original deoxygenation process. Units 1 and 2 of Qinshan Phase II originally adopted thermal deoxygenation. During long-term operation, this method presented issues such as insufficient redundancy in single-train equipment operation, high temperature and humidity on site, and potential exceedance of auxiliary feedwater tank temperature limits during summer peak temperature periods. To enhance system operational reliability, Qinshan Nuclear Power initiated relevant technical retrofits, introducing membrane separation packaged units to form a parallel standby configuration with the original thermal deoxygenation system, allowing flexible switching...

2026-08-28

Zhangzhou Nuclear Power Unit 4 Completes Hoisting of Four Internal Structure Modules

From August 18 to 27, CNNC 24 completed the hoisting of four concrete modules for the internal structure of Zhangzhou Nuclear Power Unit 4 within 10 consecutive days, covering the evaporator compartments of Loops 3, 2, and 1 as well as the pressurizer compartment, creating conditions for subsequent loop installation and commissioning work. The evaporator and pressurizer are key equipment in the nuclear island loops. The corresponding compartment concrete modules serve both load-bearing fixation and protection functions, representing an important embodiment of the "Hualong One" defense-in-depth safety philosophy at the civil construction stage. The four modules hoisted this time are all irregularly shaped structures, all adopting the "off-site prefabrication + integral modular hoisting" process, with a total hoisting weight of approximately 2,400 tons. Compared with Unit 3, Unit 4 achieved 3...

2026-08-28

Lufeng Nuclear Power Unit 1 Nuclear Island Installation and High-Quality Cold Test Sand Table Exercise Successfully Concluded

From August 18 to August 21, 2026, the China Nuclear Energy Association (hereinafter referred to as the Association) organized relevant experts to successfully carry out the sand table exercise for the nuclear island installation and high-quality cold test of Lufeng Nuclear Power Unit 1. The sand table exercise was led by Hu Guofeng, former Director of Shanghai Nuclear Engineering Research and Design Institute Co., Ltd. and Deputy Director of the Science, Technology and Development Expert Committee, with Li Jingxi, former Director of the South China Nuclear and Radiation Safety Supervision Station of the Ministry of Ecology and Environment, Li Qibin, former Chairman of China Nuclear Industry 23 Construction Co., Ltd., Zeng Hao, former Chairman of CNNC Maintenance Co., Ltd., and Wang Mingliang, former Deputy General Manager of China Nuclear Industry Fifth Construction Co., Ltd., serving as advisors. A total of 24 external experts participated...

2026-08-28

CNNC Fuyuan (Beijing) Technology Co., Ltd. officially established, focusing on accelerator and radiation technology equipment

On August 26, 2026, CNNC Fuyuan (Beijing) Technology Co., Ltd. (abbreviated as: CNNC Fuyuan) was officially established. CNNC Fuyuan is a joint venture between China Isotope & Radiation Corporation (CIRC) and CNNC Atomic Energy Institute Technology Co., Ltd., with nuclear technology equipment as its core business and radiation technology empowering industrial upgrading. Leveraging the Atomic Energy Institute's profound accumulation in accelerator technology over more than 70 years, as well as CIRC's market-oriented industrialization capabilities, the company builds a deeply integrated industry closed loop encompassing research, education, application, and utilization, strengthening and complementing the nuclear technology equipment industry chain. Looking ahead, CNNC Fuyuan will adhere to the dual-drive approach of independent innovation and achievement transformation, starting with accelerators, breaking through the boundaries of single products, and extending toward full-spectrum radiation technology,...

2026-08-28

U.S. Advanced Light Source Upgrade to Enhance Nanoscale Research Capabilities for Quantum Materials

The Advanced Light Source (ALS) at Lawrence Berkeley National Laboratory in the United States is enhancing its quantum materials research capabilities through an upgrade project. As a U.S. Department of Energy Office of Science user facility, ALS has supported researchers worldwide over the past 30+ years in studying quantum materials such as superconductors, topological insulators, and correlated electron materials, leveraging its synchrotron soft X-ray, ultraviolet, and full-spectrum X-ray experimental capabilities. Doctoral students Wei Francis He (left), Kate Matthews (second from right), and Robin Greifke (right) from the University of California, San Diego, are from the Alex Frañó research group at the ALS COSMIC beamline (7.0.1)...

2026-08-27

Argonne National Laboratory Measures Dust Resuspension Behavior in Radioactive Contamination Scenarios

Researchers at the U.S. Department of Energy's Argonne National Laboratory recently conducted field experiments to simulate the movement of dust particles on concrete surfaces under radioactive contamination scenarios, measuring the effects of pedestrian activity and vehicle traffic on dust dispersion. The study was published in the journal Health Physics and received support from the U.S. Department of Homeland Security Science and Technology Directorate and the Radiological/Nuclear Emergency Response and Recovery Research and Development Program. To control humidity and temperature and prevent dust generation, pedestrian tests were conducted inside a tent. In the image, researchers can be seen entering the tent on the left. Particle counters are placed on a white table, with their hoses extending into the tent to collect air samples. (Image courtesy of Ar...

2026-08-27

NNSA Administrator Brandon Williams Visits Kairos Power to Review SMR Technology

Kairos Power, a U.S. small modular reactor developer, recently announced that Brandon Williams, Administrator of the National Nuclear Security Administration (NNSA), has visited the company's Manufacturing Development Campus in Albuquerque, New Mexico, to review its readiness for advanced reactor deployment. According to Kairos Power, Williams and his delegation toured the campus's advanced manufacturing, fuel development, molten salt production, modular systems, and large-scale hardware verification facilities. The campus serves as a key base for the company's advancement of fluoride salt-cooled high-temperature reactor technology and also supports the engineering validation and manufacturing capability development required for future reactor deployment.

2026-08-27

Ikata Nuclear Power Station Unit 3 in Japan briefly deviated from operational limits due to abnormal signals in protection system instrumentation

Shikoku Electric Power Co. reported on August 27 that abnormal signals from safety protection system instrumentation appeared in the central control room of Ikata Nuclear Power Station Unit 3, which was in normal operation, indicating that one channel of the overtemperature ΔT related instrumentation was unreliable. The operator determined at 22:10 on August 26 that the unit had deviated from the operational limits stipulated in the Reactor Facility Security Regulations. On-site confirmation showed that the unreliable signal originated from 1 of the 4 channels of the overtemperature ΔT protection function. Overtemperature ΔT is one of the reactor automatic trip elements, used to protect in-core fuel; its limit value is calculated based on parameters such as reactor power, pressurizer pressure, and...

2026-08-27

German BESSY II Research Reveals: Cesium Chloride Seed Layer Can Improve Quality of Perovskite-Silicon Tandem Solar Cells

A team from the Helmholtz-Zentrum Berlin (HZB) in Germany used the BESSY II synchrotron radiation facility to conduct nanoscale analysis of perovskite-silicon tandem solar cells fabricated by evaporation methods, and proposed a new approach to improve the quality of perovskite thin films. The study shows that introducing a thin cesium chloride (CsCl) seed layer between the two sub-cells promotes uniform growth of the perovskite layer while reducing undesirable lead iodide deposition at the interface. The research demonstrates that the cesium chloride seed layer improves the growth of the evaporated perovskite layer and reduces the formation of lead iodide. Scanning electron microscopy images show that the perovskite layer grown without a seed layer (left image) consists of extremely fine crystallites...

2026-08-27

Japan's Helical Fusion and Tohoku University Launch Social Communication Research on Fusion Energy

Helical Fusion recently announced that it has launched a joint research project with the Takahashi-Kariwara Laboratory of the Graduate School of Engineering at Tohoku University in August 2026, focusing on ideal communication methods for the social implementation of fusion energy. The project is planned to last approximately one year, with a focus on exploring the communication methods, dialogue mechanisms, and decision-making pathways required for fusion energy to move toward social application. According to the project plan, both parties will examine cases of existing advanced technologies in areas such as social acceptance and risk perception to study communication strategies needed for the stable application of fusion energy in future society. The research also plans to introduce...

2026-08-27

South Korea's Daewoong Pharmaceutical Partners with Promedius to Promote AI Osteoporosis Screening Solution Using Chest X-rays

Daewoong Pharmaceutical announced on August 27 that it has signed a sales, distribution, and joint promotion agreement with Promedius, a medical imaging AI company, to promote Osteo Signal, an AI-based osteoporosis risk screening solution using chest X-rays, in South Korea. This partnership also marks Daewoong Pharmaceutical's expansion from its existing osteoporosis treatment business into the AI-assisted diagnostics field. Under the agreement, Daewoong Pharmaceutical will leverage its business network covering medical institutions across South Korea, along with its sales and marketing capabilities, to bring the solution into more clinical settings. Promedius will provide medical imaging AI technical support to assist in its deployment in real-world medical environments.

2026-08-27

Hyogo Medical University Hospital to Launch Japan's First Elekta Evo Linear Accelerator System Treatments

Elekta K.K. announced on August 27 that its high-precision radiation therapy device, the Elekta Evo linear accelerator system, will be installed for the first time in Japan at Hyogo Medical University Hospital, with the first treatment scheduled to commence on September 24, 2026. This marks the entry of this next-generation radiation therapy system into clinical application in Japan. As the number of cancer patients increases, the demand for personalized and precise treatment in the field of radiation therapy continues to rise. The Elekta Evo is positioned as a next-generation radiation therapy system capable of covering both routine and more complex cancer treatment scenarios. The system is equipped with Iris, an AI-driven high-definition imaging technology, which enables clearer visualization of the positional relationships between organs in the patient's body...

2026-08-27

South Korea's POSCO Group Invests in Japanese Fusion Company Kyoto Fusion Engineering

South Korea's POSCO Group has invested in Japanese fusion energy company Kyoto Fusion Engineering (KF) to establish an early presence in the global fusion energy market and explore new business opportunities in future steel, specialty materials, and energy infrastructure. According to industry sources on the 27th, POSCO Group participated in Kyoto Fusion Engineering's Series D funding round. The investment was made through the Korea-Japan Fusion Fund, established by IMM Investment Japan (IMMJ) together with Korean and Japanese investors. POSCO Holdings and POSCO International also contributed to the fund...

2026-08-27

Sichuan Huadu Nuclear Energy Wins Control Rod Drive Mechanism Orders for 4 Nuclear Power Units

On August 24, news came from Sichuan Huadu Nuclear Equipment Manufacturing Co., Ltd., located in Dujiangyan, Chengdu, Sichuan, that the company has won the orders for control rod drive mechanisms for 4 units among the first batch of nuclear power units approved for construction during the 15th Five-Year Plan period in China, with a total new contract value of 504 million yuan. The winning projects include Units 3 and 4 of Zhejiang Jinqimen Nuclear Power Plant, as well as Units 1 and 2 of Phase I of Liaoning Zhuanghe Nuclear Power. According to the previous approval arrangement by the State Council Executive Meeting, the new batch of nuclear power projects involves a total of 4 projects and 8 units, including Phase II of Zhejiang Jinqimen Nuclear Power, Phase III of Guangdong Taipingling Nuclear Power, Phase I of Liaoning Zhuanghe Nuclear Power, and Phase I of Shandong Laiyang Nuclear Power, all adopting China's self-developed third-generation nuclear power technology...

2026-08-27

Huzhou, Zhejiang Launches Phase I "Drug-Device Combination" Clinical Trial for the Province's First BNCT System

Recently, the Boron Neutron Tumor Treatment Center at Huzhou Hospital Affiliated to Zhejiang University School of Medicine has drawn attention with the introduction of the province's first Boron Neutron Capture Therapy (BNCT) system. Previously, the system had already initiated a Phase I BNCT drug-device combination clinical trial. According to the system developer, Huapeng Neutron Technology (Hangzhou) Co., Ltd., BNCT is a radiotherapy technique combining drugs and devices, with its core lying in the coordinated use of boron-containing drugs and neutron irradiation. After entering the human body, the boron-containing drug can be absorbed by tumor cells; subsequent neutron beam irradiation triggers a localized reaction to achieve targeted radiotherapy against tumor cells. Unlike conventional radiotherapy, which typically employs fractionated irradiation over a longer treatment course, BNCT emphasizes selective targeting of tumor cells, aiming to reduce damage to surrounding healthy tissues and lower radiotherapy-related side effects such as hair loss and immunosuppression.

2026-08-27